Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine
Vivette D. D’Agati, Satoru Kudose, Andrew S. Bomback, Ananea Adamidis, Albert Tartini
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Minimal change disease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Kidney diseaseVaccinationAdverse effectNephrotic syndromeAcute kidney injuryDiseaseInternal medicinePathologyKidneyGlomerulonephritisFocal segmental glomerulosclerosisOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisRetinal and Optic Conditions